Join the club for FREE to access the whole archive and other member benefits.

Birgit Schilling

Professor at Buck Institute for Research on Aging

Birgit Schilling is the Director of the Mass Spectrometry Core and a Professor at The Buck Institute for Research on Aging. Dr. Schilling studied Chemistry at the University of Hamburg and received her Doctorate (PhD) from the University of Clausthal, Germany. Dr. Schilling obtained additional research training as a postdoctoral fellow at UCSF, and joined the Buck Institute in 2000. She is also Adjunct Professor at University of Southern California and is teaching at the Buck Institute as part of the joined Buck Institute/USC PhD program.

Dr. Schilling and the Mass Spectrometry Core provide expertise in mass spectrometry to efficiently analyze biological samples, for example to determine changes in protein expression or protein modifications as a result of a disease or other biological conditions. Collaborative research projects investigated at the Mass Spectrometry Core comprise projects related to neurodegenerative diseases, aging, cancer, muscle atrophy, protein posttranslational modifications, mitochondrial damage, biomarker research, and many other scientific areas. Specific areas of interest are a sarcopenia project deciphering underlying causes and biological pathways of muscle atrophy, as well as the role of sirtuins on posttranslational modifications of proteins.

Visit website: https://www.buckinstitute.org/lab/schilling-lab/

 birgit-schilling-4a59409b

See also: Institute Buck Institute - Independent biomedical research institute focused on aging

Details last updated 07-Apr-2023

Birgit Schilling is also referenced in the following:

Age-Related Disease Therapeutics Summit

31-May-2023 to 02-Jun-2023

Event about aging and aging related diseases organized by Hanson Wade

Birgit Schilling News

A new method called FAST studies cellular ageing in cultured cells

Live Forever Club - 18-Jan-2024

FAST is precise and works with different cell types and microscopes

Read more...

Reason reports back from Age-Related Disease Therapeutics Summit 2023

Fight Aging! - 16-Jun-2023

Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years

Read more...